1. Home
  2. AIMD vs STRR Comparison

AIMD vs STRR Comparison

Compare AIMD & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • STRR
  • Stock Information
  • Founded
  • AIMD 1984
  • STRR 1985
  • Country
  • AIMD United States
  • STRR United States
  • Employees
  • AIMD N/A
  • STRR N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AIMD Health Care
  • STRR Health Care
  • Exchange
  • AIMD Nasdaq
  • STRR Nasdaq
  • Market Cap
  • AIMD 11.9M
  • STRR 6.3M
  • IPO Year
  • AIMD N/A
  • STRR N/A
  • Fundamental
  • Price
  • AIMD $2.86
  • STRR $1.96
  • Analyst Decision
  • AIMD
  • STRR Strong Buy
  • Analyst Count
  • AIMD 0
  • STRR 1
  • Target Price
  • AIMD N/A
  • STRR $5.00
  • AVG Volume (30 Days)
  • AIMD 75.3K
  • STRR 9.5K
  • Earning Date
  • AIMD 08-04-2025
  • STRR 08-12-2025
  • Dividend Yield
  • AIMD N/A
  • STRR N/A
  • EPS Growth
  • AIMD N/A
  • STRR N/A
  • EPS
  • AIMD N/A
  • STRR N/A
  • Revenue
  • AIMD $106,207.00
  • STRR $57,165,000.00
  • Revenue This Year
  • AIMD N/A
  • STRR $33.64
  • Revenue Next Year
  • AIMD N/A
  • STRR $22.87
  • P/E Ratio
  • AIMD N/A
  • STRR N/A
  • Revenue Growth
  • AIMD 13.38
  • STRR 34.33
  • 52 Week Low
  • AIMD $2.00
  • STRR $1.72
  • 52 Week High
  • AIMD $5.00
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 48.86
  • STRR 45.04
  • Support Level
  • AIMD $3.07
  • STRR $1.95
  • Resistance Level
  • AIMD $3.34
  • STRR $2.03
  • Average True Range (ATR)
  • AIMD 0.24
  • STRR 0.05
  • MACD
  • AIMD 0.01
  • STRR 0.01
  • Stochastic Oscillator
  • AIMD 54.84
  • STRR 27.27

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

Share on Social Networks: